EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Treatment of pediatric epilepsy

Junxiao Li, Tinghong Liu iD, Chang Liu, Jie Deng iD, Shijie Wu, Suhui Kuang, Xiaotong Li, Zhirong Wei, Shuli Liang iD

Pediatric Investigation · 2026-02 · 10 (1) · 86-100

DOI: 10.1002/ped4.70043 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Investigation, online erschienen am 29.01.2026. Verfasst von Junxiao Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Functional Neurosurgery Department National Center for Children's Health Beijing Children's Hospital Capital Medical University Beijing China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric epilepsy is a neurological disorder arising from various etiologies, including structural, genetic, immune, infectious, metabolic, and unknown causes. Anti‐seizure medications remain the primary treatment; however, in cases of drug‐resistant epilepsy, surgical interventions, ketogenic diet, and emerging therapies have become increasingly effective options. Disease‐modifying treatments, such as antisense oligonucleotides and adeno‐associated virus–mediated gene replacement, have shown promise in some epilepsy treatments, with early trials reporting moderate seizure reduction. Minimally invasive surgical approaches, including magnetic resonance–guided laser interstitial thermal therapy, have also demonstrated favorable outcomes, showing a 68% seizure‐free rate at 2 years in the largest pediatric series. Although the ketogenic diet is effective in some patients, demonstrating superiority over conventional management for >50% seizure reduction, long‐term use may be associated with metabolic risks; careful monitoring is warranted. Future treatment strategies are expected to emphasize personalized medicine through the integration of genetic, electrophysiological, and neuroimaging data to optimize therapeutic decision‐making and enable targeted interventions based on the underlying etiology.

Schlagwörter

Stichwörter der Autor:innen

Anti‐seizure medicationsChildrenDisease‐modifying treatmentsEpilepsyKetogenic dietSurgery

Autor:innen und Institutionen

  • Functional Neurosurgery Department National Center for Children's Health Beijing Children's Hospital Capital Medical University Beijing China.
  • Neurosurgery Department Renji Hospital Shanghai Jiao Tong University Shanghai China.
  • Neurology Department National Center for Children's Health Beijing Children's Hospital Capital Medical University Beijing China.
  • Neurosurgery Department National Center for Children's Health Beijing Children's Hospital Capital Medical University Beijing China.

ORCID-Profile: Tinghong Liu, Jie Deng, Shuli Liang

Zitieren

APA

Li, J., Liu, T., Liu, C., Deng, J., Wu, S., Kuang, S., Li, X., Wei, Z., & Liang, S. (2026). Treatment of pediatric epilepsy. Pediatric Investigation, 10(1), 86-100. https://doi.org/10.1002/ped4.70043

Vancouver

Li J, Liu T, Liu C, Deng J, Wu S, Kuang S, et al. Treatment of pediatric epilepsy. Pediatric Investigation. 2026;10(1):86-100. doi:10.1002/ped4.70043

BibTeX
@article{Li2026,
  author = {Li, Junxiao and Liu, Tinghong and Liu, Chang and Deng, Jie and Wu, Shijie and Kuang, Suhui and Li, Xiaotong and Wei, Zhirong and Liang, Shuli},
  title = {Treatment of pediatric epilepsy},
  journal = {Pediatric Investigation},
  year = {2026},
  volume = {10},
  number = {1},
  pages = {86--100},
  doi = {10.1002/ped4.70043}
}
Kostenlos starten →